Small caps round-up: United Drug, Regenersis, Pantheon...

Pharmaceutical firm United Drug has entered into a joint venture with Medco Health Solutions to provide home-based pharmacy care services in the UK for patients covered by the NHS.The joint venture, which will operate in the U.K. as Medco Health Solutions, plans to offer patients treated within the NHS system a suite of homecare services ranging from prescription drug dispensing and home-delivery, to on-site nursing for the administration of oral, injectable and infused agents, and case-management capabilities. "United Drug's experienced healthcare professionals, advanced distribution capability and deep NHS knowledge complement Medco's innovative technologies, clinical expertise and financial resources to accelerate our ability to deliver these critical capabilities across the United Kingdom and meet NHS' goals of providing world-class care' said Liam FitzGerald, Chief Executive of United Drug.Regenersis is up at a two-month high after mobile phone maker Nokia chose the handset repairer as an exclusive technical support partner to the Nokia UK Care Network. "Our solution dramatically reduces lead times for training and development, allowing the Nokia Care Points to service more products on-site, while improving their ability to deliver additional benefits to customers," said Regenersis CEO Gary Stokes. Pantheon Resources believes an 'unconsolidated rubble zone' was partly responsible for mechanical difficulties while drilling the Vision Rice University #1 well in Texas.But chief executive Jay Cheatham is "very excited" by the positive implications for the overall project. "Such a zone may enable the joint venture to drill fewer wells at an overall lower cost to achieve the expected production rates and recoverability."There are gains for mining services group MDM Engineering on news it has won a contract for the pre-feasibility study for CAMEC's Licence 871L project in Mozambique.An initial assessment of the licence area revealed that the project has 'world class' potential. Henderson Morley, the AIM quoted biotechnology company, gained on news that its Koi Herpes Virus (KHV) Vaccine field study has produced positive results.Silicon Valley tech companies venture capital specialist Berkeley Technology said the value of its private equity investments held steady in the second quarter of 2009.The company reported a loss before tax of $0.75m in the three months to the end of June, compared to a loss of $0.63m the year before. Feed additives company Kiotech International saw its shares put on a growth spurt on Thursday after the company declared a 59.5% increase in profit before interest and tax for the first half of 2009, to £0.28m from £0.17m the year before.Sales climbed 29% to £3.47m from £2.69m, while cash grew to £1.78m from £1.39m at the end of June 2008."We have made a strong start to the second half of the year continuing the sales growth of the first half. Management remains focused on generating sales from new territories particularly Brazil and China, which are key agricultural markets and where we currently have no presence"Specialist education and sports information provider Electric Word has raised £2.45m (net) through a placing of shares at 3.625p each. The funds will be used to pay down debt.The announcement accompanied the release of interim results which saw the company boost pre-tax profit in the six months to 31 May 2009 to £0.53m from £0.29m the year before. Adjusted pre-tax profit, which excludes various exceptional items, rose 19% to £0.8m. Over the same period revenue edged lower to £8.72m from £8.95m the year before.Current trading is in line with the board's expectations.The executive chairman of software supplier Formjet said the company "has weathered a serious storm" during a first half of the year in which management's main aim was to stabilise the business.Revenue from continuing operations in the first half of the year declined to £1.45m from £1.75m in the first half of last year, while losses before tax widened to £0.19m from £0.84m.